CVET - CVET STOCK NEWS

Covetrus (NASDAQ: CVET) will release its Q1 2022 results after market close on May 5, 2022, followed by a conference call at 4:30 PM ET. CEO Ben Wolin and CFO Matthew Foulston will discuss the results.

Investors can access the conference call via registration on the Investor Relations site. A replay will be available for two weeks post-call. Covetrus provides animal health technology and services, aiming to enhance veterinary practice outcomes.

Covetrus, a global leader in animal-health technology, has appointed Matt Salois, Ph.D., as President of its subsidiary, Veterinary Study Groups, Inc. (VSG). He will enhance the success of VSG, which serves over 1,800 veterinary practices. Salois brings extensive experience from his previous role as Chief Economist at the American Veterinary Medical Association. He aims to leverage data and analytics to support veterinary practices in improving health outcomes and managing workforce challenges.

Covetrus reported Q4 2021 net sales of $1.12 billion, unchanged year-over-year, with a GAAP net loss of $(3) million. Full-year 2021 net sales reached $4.58 billion, a 5% increase, but a GAAP net loss totaled $(54) million. Non-GAAP organic net sales grew 2% in Q4 and 5% for the year. Adjusted EBITDA for Q4 was $63 million, up 13%, while full-year adjusted EBITDA totaled $244 million, an 8% increase. For 2022, Covetrus projects organic net sales growth of 7% to 8% and adjusted EBITDA of $270 to $280 million.

Covetrus (NASDAQ: CVET) will announce its fourth-quarter and full-year 2021 results on February 24, 2022, post-market. A conference call with CEO Benjamin Wolin and CFO Matthew Foulston is scheduled for 4:30 PM ET to discuss the results. Investors can access the live webcast via the Investor Relations page on Covetrus' website, where a recorded version will also be available. Covetrus, headquartered in Portland, Maine, serves over 100,000 customers globally, focusing on animal health technology and services.

Henry Schein reported fourth-quarter 2021 net sales of $3.3 billion, a 5.2% increase year-over-year. GAAP diluted EPS from continuing operations rose to $1.05, up from $0.99 a year earlier. Non-GAAP diluted EPS also increased to $1.07 from $1.00.

The company projects 2022 GAAP diluted EPS between $4.75 and $4.91, reflecting 7% to 10% growth from 2021. Global dental sales reached $2.0 billion for the quarter, a 9.4% rise, while medical sales declined by 3.2%. The company continues to focus on operational improvements and technology services.

Covetrus (NASDAQ: CVET), a leader in animal-health technology, appointed César França as President of Global Proprietary Brands. França, who has over 25 years of experience, will manage the company's proprietary brand portfolio, including Kruuse and Calibra. His role focuses on brand development, strategic partnerships, and growth opportunities. His previous experience at Nestlé enhances his capability to drive profitability and sustainability. Covetrus aims to empower veterinary practices and improve health outcomes globally.

Covetrus (NASDAQ: CVET) has launched Covetrus Pulse™, a cloud-based veterinary operating system designed to streamline practice management for veterinarians. The platform integrates all essential applications into a single interface, enhancing operational efficiency and client experience. A survey indicated that 95% of veterinarians prioritize practice efficiency, and 70% prefer an all-in-one solution. Launching on April 1, industry professionals will preview the product at the Veterinary Meeting & Expo from January 15–19, 2022, with additional details announced during the Western Veterinary Conference in March.

Covetrus (NASDAQ: CVET), a leader in animal-health technology, will participate in the 40th Annual J.P. Morgan Healthcare Conference on January 12, 2022. The company's CEO, Benjamin Wolin, and CFO, Matthew Foulston, will present virtually at 10:30 a.m. ET and engage with analysts. Interested parties can access the live audio webcast and presentation on Covetrus' Investor website, with a replay available for 90 days. Covetrus, headquartered in Portland, Maine, serves over 100,000 customers globally, delivering innovative veterinary solutions.

Covetrus (Nasdaq: CVET) has announced a new organizational structure for its Northern and Central Europe operations as part of its three-year strategic plan. The company will create a DACH headquarters in Düsseldorf, Germany, effective April 1, 2022, enhancing its commercial capabilities in the German and U.K. markets. This restructuring involves relocating from Hamburg to Düsseldorf and forming a new International leadership team to unify operations. The changes aim to address regional pressures and improve customer service.